5 year follow-up results of the HERAKLES study: superior renal function after early conversion to an everolimus-based calcineurin inhibitor free regimen.

被引：0
|
作者：
Sommerer, Claudia [1 ]
Budde, Klemens [1 ]
Arns, Wolfgang [1 ]
Reinke, Petra [1 ]
Guba, Markus [1 ]
Weithofer, Peter [1 ]
Vogt, Bruno [3 ]
Jacobi, Johannes [1 ]
Stahl, Rolf [1 ]
Rath, Thomas [1 ]
Hauser, Ingeborg A. [1 ]
Porstner, Martina [2 ]
May, Christoph [2 ]
Lehner, Frank [1 ]
Witzke, Oliver [1 ]
机构：
[1] Herakles, Study Grp, Berlin, Germany
[2] Novartis, Pharma, Wehr, Germany
[3] Herakles, Study Grp, Basel, Switzerland
来源：
TRANSPLANTATION | 2016年 / 100卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P.1528
引用
收藏
页码：S724 / S724
页数：1
相关论文
共 50 条
  • [21] RENAL FUNCTION OF AN EVEROLIMUS BASED THERAPY AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS ONE YEAR AFTER CONVERSION
    Reinke, P.
    Rath, T.
    Budde, K.
    Arns, W.
    Kramer, S.
    Vogel, E. -M.
    Pietruck, F.
    Haller, H.
    Sommerer, C.
    [J]. TRANSPLANT INTERNATIONAL, 2010, 23 : 48 - 48
  • [22] Effect of Calcineurin Inhibitor-Free, Everolimus-Based Immunosuppressive Regimen on Albuminuria and Glomerular Filtration Rate After Heart Transplantation
    Nelson, Laerke Marie
    Andreassen, Arne Kristian
    Andersson, Bert
    Gude, Einar
    Eiskjaer, Hans
    Radegran, Goran
    Dellgren, Goran
    Gullestad, Lars
    Gustafsson, Finn
    [J]. TRANSPLANTATION, 2017, 101 (11) : 2793 - 2800
  • [23] 5 YEARS FOLLOW-UP ON RENAL FUNCTION - ZEUS TRIAL: IMPROVED RENAL FUNCTION OF AN EVEROLIMUS/ENTERIC-COATED MYCOPHENOLATE SODIUM REGIMEN AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN DE NOVO RENAL TRANSPLANT PATIENTS
    Reinke, P.
    Lehner, F.
    Witzke, O.
    Sommerer, C.
    Eisenberger, U.
    Arns, W.
    Porstner, M.
    May, C.
    Paulus, E. -M.
    Budde, K.
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 21 - 21
  • [24] Incidence of donor-specific antibodies in kidney transplant patients following conversion to an everolimus-based calcineurin inhibitor-free regimen
    Kamar, Nassim
    Del Bello, Arnaud
    Congy-Jolivet, Nicolas
    Guilbeau-Frugier, Celine
    Cardeau-Desangles, Isabelle
    Fort, Marylise
    Esposito, Laure
    Guitard, Joelle
    Game, Xavier
    Rostaing, Lionel
    [J]. CLINICAL TRANSPLANTATION, 2013, 27 (03) : 455 - 462
  • [25] IMPROVED RENAL FUNCTION OF AN EVEROLIMUS/ENTERIC-COATED MYCOPHENOLATE SODIUM REGIMEN AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN DE NOVO RENAL TRANSPLANT PATIENTS: 3 YEAR FOLLOW-UP OF THE ZEUS TRIAL
    Lehner, Frank
    Budde, Klemens
    Arns, Wolfgang
    Sommerer, Claudia
    Reinke, Petra
    Eisenberger, Ute
    Vogel, Eva-Maria
    Scheidl, Stefan
    Witzke, Oliver
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 57 - 57
  • [26] Long-term follow-up of five yr shows superior renal function with everolimus plus early calcineurin inhibitor withdrawal in the PROTECT randomized liver transplantation study
    Sterneck, Martina
    Kaiser, Gernot M.
    Heyne, Nils
    Richter, Nicolas
    Rauchfuss, Falk
    Pascher, Andreas
    Schemmer, Peter
    Fischer, Lutz
    Klein, Christian G.
    Nadalin, Silvio
    Lehner, Frank
    Settmacher, Utz
    Gotthardt, Daniel
    Loss, Martin
    Ladenburger, Stephan
    Wimmer, Peter
    Dworak, Markus
    Schlitt, Hans J.
    [J]. CLINICAL TRANSPLANTATION, 2016, 30 (06) : 741 - 748
  • [27] CONVERSION TO AN EVEROLIMUS/ENTERIC-COATED MYCOPHENOLATE SODIUM REGIMEN AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN DE NOVO RENAL TRANSPLANT PATIENTS IMPROVES RENAL FUNCTION: 2 YEARS FOLLOW-UP OF THE ZEUS TRIAL
    Sommerer, C.
    Becker, T.
    Budde, K.
    Pietruck, F.
    Eisenberger, U.
    Fischer, W.
    Kramer, S.
    Reinke, P.
    Arns, W.
    [J]. TRANSPLANT INTERNATIONAL, 2010, 23 : 60 - 60
  • [28] Improved Renal Function of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in De Novo Renal Transplant Patients: 5 Years Follow-Up of the ZEUS Trial
    Budde, K.
    Witzke, O.
    Sommerer, C.
    Reinke, P.
    Eisenberger, U.
    Paulus, E.
    Porstner, M.
    May, C.
    Arns, W.
    Lehner, F.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 35 - 36
  • [29] Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial
    de Fijter, J. W.
    Holdaas, H.
    Oyen, O.
    Sanders, J. -S.
    Sundar, S.
    Bemelman, F. J.
    Sommerer, C.
    Pascual, J.
    Avihingsanon, Y.
    Pongskul, C.
    Oppenheimer, F.
    Toselli, L.
    Russ, G.
    Wang, Z.
    Lopez, P.
    Kochuparampil, J.
    Cruzado, J. M.
    van der Giet, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (07) : 1853 - 1867
  • [30] Conversion from a calcineurin inhibitor-based immunosuppressive regimen to everolimus in renal transplant recipients: Effect on renal function and proteinuria
    Morales, J.
    Fierro, A.
    Benavente, D.
    Zehnder, C.
    Ferrario, M.
    Contreras, L.
    Herzog, C.
    Buckel, E.
    [J]. TRANSPLANTATION PROCEEDINGS, 2007, 39 (03) : 591 - 593
12345